Abstract
The aim of the study was to assess the efficacy of salmon calcitonin, which was suggested as effective in the treatment of complex regional pain syndrome type 1 (CRPS 1). Patients who had suffered trauma to their upper extremities and developed CRPS 1 were included into this randomised, controlled single-blind study. The diagnosis was made according to the clinical examination and scintigraphy. The evaluation parameters were: pain [visual analogue scale (VAS)], the angle of dorsiflexion (DF) and palmar flexion (PF) of the wrist, distance between the fingertip and distal palmar crease (FT-DPC), allodynia, hyperalgesia and trophic changes. One group received paracetamol 1500 m/day and the other group salmon calcitonin 200 IU/day for 2 months. All of the patients participated in a physical therapy and exercise programme. A total of 35 patients were divided into two groups, who were found to be similar for age, body mass index, period of trauma, period of rest in a plaster splint or bandage, the duration of symptoms, VAS, DF and PF angle, FT-DPC, presence of allodynia, hyperalgesia and trophic changes (p>0.05). The control examination showed similar results for allodynia, hyperalgesia and trophic changes, whereas remarkable improvement was observed in the rest of the parameters within groups. On the other hand, between the two groups there was no significant difference in any of the parameters (p>0.05) This randomised, single-blind study showed that all of the patients with acute CRPS 1 in their upper extremities after trauma, who were treated with either paracetamol or calcitonin along with physical therapy, recovered in all parameters significantly, but without any difference between groups. We can conclude that calcitonin does not make any favourable contribution in the treatment of patients with acute CRPS 1; physical therapy combined with only a simple analgesic is an efficient means of therapy.
Similar content being viewed by others
References
Schurmann M, Grandi G, Andress HJ, Furst H, Schildberg FW (1999) Assessment of peripheral sympathetic nervous function for diagnosing early post-traumatic complex regional pain syndrome type 1. Pain 80:149–159
Baron R (2000) Peripheral neuropathic pain: from mechanisms to symptoms. Clin J Pain 16:201–204
Woolf CJ, Mannion RJ (1999) Neuropathic pain: aetiology, symptoms, mechanisms and management. Lancet 353:1959–1964
Schwartzman RJ (2000) New treatments for reflex sympathetic dystrophy. N Engl J Med 343:654–656
Marshall AT, Crisp AJ (2000) Reflex sympathetic dystrophy. Rheumatology 39:692–695
Doury P, Dequeker J (1998) Algodystrophy/reflex sympathetic dystrophy syndrome. In: Klippel JH, Dieppe PA (eds) Rheumatology, 2nd edn. Mosby International, London pp 8441–8448
Appelbloom T (2002) Calcitonin in reflex sympathetic dystrophy syndrome and other painful conditions. Bone 30:84S-86S
Gobelet C, Waldburger M, Meier JL (1992) The effect of adding calcitonin to physical treatment on reflex sympathetic dystrophy. Pain 48:171–175
Bickerstaff DR, Kanis JA (1991) The use of calcitonin in the treatment of post-traumatic algodystrophy. Br J Rheumatol 30:291–294
Geusens P, Santen M (2000) Algodystrophy. Baillieres Best Pract Res Clin Rheumatol 14:499–513
Brody MC, Andary MT (1993) Treatment approaches to reflex sympathetic dystrophy. Phys Med Rehabil Clin North Am 4:165–174
Kozin F, Genant HK, Bekerman C, McCarthy DJ (1976) The reflex sympathetic dystrophy syndrome. II. Roentgenographic and scintigraphic evidence of bilaterality and of periarticular accentuation. Am J Med 60:332–338
Genant HK, Kozin F, Bekerman C, McCarthy DJ, Sims J (1975) The reflex sympathetic dystrophy: comprehensive analysis using fine-detail radiography, photon absorptiometry and bone and joint scintigraphy. Radiology 117:21–32
Basford JR (1998) Physical agents. In: DeLisa JA, Gans BM (eds) Rehabilitation Medicine, 3rd edn. Lippincott-Raven, Philadelphia, pp 483–503
Van Laere M, Ciaessens M (1992) The treatment of reflex sympathetic dystrophy syndrome: current concepts. Acta Orthop Belg 58 [Suppl 1]:259–261
Azria M (2002) Possible mechanisms of the analgesic action of calcitonin. Bone 30:80S-83S
Lyritis GP, Trovas G (2002) Analgesic effects of calcitonin. Bone 30:71S-74S
Schurmann M, Vogel T, Gartner A, et al. (2001) Experiences with calcitonin treatment of patients with type 1 complex regional pain syndrome (CRPS I-Sudeck disease). Z Orthop Ihre Grenzgeb 139:452–457
Hamamci N, Dursun E, Ural C, Cakci A (1996) Calcitonin treatment in reflex sympathetic dystrophy: a preliminary study. Br J Clin Pract 50:373–375
Gobelet C, Meier JL, Schaffner W, Bischof-Delaloye A, Gerster JC, Burchardt P (1986) Calcitonin and reflex sympathetic dystrophy syndrome. Clin Rheumatol 5:382–388
Perez RS, Kwakkel G, Zuurmond WW, de Lange JJ (2001) Treatment of reflex sympathetic dystrophy (CRPS type 1): a research synthesis of 21 randomized clinical trials. J Pain Symptom Manage 211:511–526
Kingery WS (1997) A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 77:123–139
Bickerstaff DR (1991) The natural history of post-traumatic algodystrophy. J Bone Joint Surg Br 73:167
Author information
Authors and Affiliations
Corresponding author
Additional information
Published online: 25 June 2005
Rights and permissions
About this article
Cite this article
Sahin, F., Yilmaz, F., Kotevoglu, N. et al. Efficacy of salmon calcitonin in complex regional pain syndrome (type 1) in addition to physical therapy. Clin Rheumatol 25, 143–148 (2006). https://doi.org/10.1007/s10067-005-1153-2
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10067-005-1153-2